1
Lenzi A, Sgro P, Salacone P,
et al. A placebo-controlled
double-blind randomized trial
of the use of combined
l-carnitine and
l-acetyl-carnitine treatment
in men with asthenozoospermia.
Fertil Steril 2004;81:1578-84.
2
Krajcovicova-Kudlackova M,
Simoncic R, Bederova A,
Babinska K, Beder I.
Correlation of carnitine
levels to methionine and
lysine intake. Physiol Res.
2000;49(3):399-402.
3 Rebouche CJ.
Kinetics, pharmacokinetics,
and regulation of L-carnitine
and acetyl-L-carnitine
metabolism. Ann N Y Acad Sci
2004;1033:30-41.
4 Hurot JM,
Cucherat M, Haugh M, Fouque D.
Effects of L-carnitine
supplementation in maintenance
hemodialysis patients: a
systematic review. J Am Soc
Nephrol 2002;13:708-14.
5 Online
document at:
www.naturaldatabase.com
6 Iliceto S,
Scrutinio D, Bruzzi P, et al.
Effects of L-carnitine
administration on left
ventricular remodeling after
acute anterior myocardial
infarction: the L-Carnitine
Ecocardiografia Digitalizzata
Infarto Miocardico (CEDIM)
Trial. J Am Coll Cardiol
1995;26:380-7.
7 Anonymous.
Carnitor (levocarnitine)
package insert. Sigma-Tau
Pharmaceuticals Inc,
Gaithersburg, MD. December
1999.
8 Evans AM,
Fornasini G. Pharmacokinetics
of L-carnitine. Clin
Pharmacokinet 2003;42:941-67..
9 Tsoko M,
Beauseigneur F, Gresti J, et
al. Enhancement of activities
relative to fatty acid
oxidation in the liver of rats
depleted of L-carnitine by
D-carnitine and a gamma-
butyrobetaine hydroxylase
inhibitor. Biochem Pharmacol
1995;49:1403-10. 9 Ibid
10 Wu X,
Huang W, Prasad PD, et al.
Functional characteristics and
tissue distribution pattern of
organic cation transporter 2
(OCTN2), an organic cation/carnitine
transporter. J Pharmacol Exp
Ther 1999;290:1482-92.
11
Famularo G, De Simone C,
Cifone G. Carnitine stands on
its own in HIV infection
treatment. Arch Intern Med
1999;159:1143-4.
12 Moretti S.
Effect of L-carnitine on human
immunodeficiency virus-1
infection-associated
apoptosis: a pilot study.
Blood 1998;91:3817-24.
13 Young DS.
Effects of Drugs on Clinical
Laboratory Tests 4th ed.
Washington: AACC Press, 1995.
14 Benvenga
S, Amato A, Calvani M,
Trimarchi F. Effects of
carnitine on thyroid hormone
action. Ann N Y Acad Sci
2004;1033:158-67.
15 Hug G,
McGraw CA, Bates SR, et al.
Reduction of serum carnitine
concentrations during
anticonvulsant therapy with
phenobarbital, valproic acid,
phenytoin, and carbamazepine
in children. J Pediatr
1991;119:799-802.
16 Brass EP.
Pivalate-generating prodrugs
and carnitine homeostasis in
man. Pharmacol Rev
2002;54:589-98. 16 Ibid
17 Castro-Gago
M, Eiris-Punal J,
Novo-Rodriguez MI, et al.
Serum carnitine levels in
epileptic children before and
during treatment with valproic
acid, carbamazepine, and
phenobarbital. J Child Neurol
1998;13:546-9. 17 Ibid
18 De Vivo
DC, Bohan TP, Coulter DL, et
al. L-carnitine
supplementation in childhood
epilepsy: Current
perspectives. Epilepsia
1998;39:1216-25.
19 Georges B,
Galland S, Rigault C, et al.
Beneficial effects of
L-carnitine in myoblastic
C2C12 cells. Interaction with
zidovudine. Biochem Pharmacol
2003;65:1483-8.